BioSpace News Archive

Dario Membership users with diabetes achieved a 39% increase of in-range, blood-glucose measurements

binx io enables first-ever “test-and-treat” paradigm with sample to answer in 30 minutes for the two most tested-for sexually transmitted infections (STIs)

Shawn Iadonato, Kineta Chief Executive Officer, will provide a corporate overview on Thursday, August 15, 2019 at 2:00PM, Eastern Time.

°CRYO Science™, the world’s leading innovator in cryotherapy solutions and applications, produces the safest and most effective cryotherapy machines available. In a recent Instagram video, world-famous actor and fitness fanatic Mark Wahlberg called the °CRYO Arctic™ “the number one cryotherapy machine.”

BioLife Solutions, Inc. announced that representatives of the Company will be attending, exhibiting, and/or presenting at the following upcoming scientific and investor conferences:

Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), today announced that an abstract highlighting the results of the SPECTRUM study evaluating Brinavess® (vernakalant hydrochloride, IV), the Company’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), was selected for a poster presentation at the European Society of Cardiology (ESC) 2019 Congress taking place August 31 – September 4, 2019, in Paris.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced the effective change of its corporate name and formal launch of its new corporate brand. In connection with the launch, the Company’s NYSE American ticker symbol has changed to “LCTX” and will be effective at the open of the market today